Complex DCT Delivery — What is Possible Outside of a Site?

Life Sciences, Clinical Trials, Patient Recruitment & Retention,
  • Monday, November 28, 2022

How do you retain patients in a complex trial? For clinical research professionals, testing medications and procedures on patient populations who feel unwell and have mobility or logistical challenges can be taxing, physically, mentally and emotionally for patients and their families — disruptive to their everyday lives and to the everyday lives of their families. Could incorporating decentralized clinical trial (DCT) visits help?

For many clinical trialists, patient retention and engagement, especially in a complex trial, are challenges that keep them up at night, worrying that valuable patients will not complete the trial. A DCT is proven to improve patient retention, but if it’s a method of conducting research that the trialist hasn’t experienced before, the benefit, value and possibilities when building decentralized trial visits into a protocol, might not be fully realized.

There are many procedures that can be completed in the home, and a significant number of those are far more complex than anticipated. From double blinded healthcare professionals delivering IMP, to timed pharmacokinetic blood draws and digitally linked visits, there are so many complex visit types that can be delivered in a DCT.

Register for this webinar to hear Todd McGrath, Chief Operating Officer, and Emily McDougal, Executive Director Nurse Management, talk about how MRN’s decentralized delivery of complex clinical visits benefits clinical trials, sites and patients.


Todd McGrath, MRN

Todd McGrath, Chief Operating Officer, MRN

Todd has over 18 years’ experience in the clinical trial and life science industry; beginning his career in pharmaceutical and biotech consulting and then holding operational positions at PAREXEL managing teams and projects.

Today, Todd is MRNs Chief Operating Officer and oversees all of the global operations for the company. Todd’s leadership has been instrumental to MRN’s pharma clients, guiding them through operational challenges, and his passion for making trials more accessible and less burdensome for patients and their families, continues to drive MRNs vision of allowing more people to participate in trials and getting drugs to the market and patients, faster.

Message Presenter
Emily McDougal, MRN

Emily McDougal, Executive Director Nurse Management, MRN

Emily has over 20 years of nursing experience with 12 years in clinical research nursing and operational delivery. She joined MRN in January 2022 as the Executive Director of Nurse Management, a key clinical leadership position in the company heading the nursing function globally. Emily is an expert in operational clinical delivery, nursing governance and patient safety. Prior to her current position with MRN, Emily has worked as an Associated Director of Research Nursing with project management responsibilities, as well as, Senior Delivery Manager with National Institute of Health Research, Clinical Research Networks in the UK.

As a senior nurse, Emily brings a wealth of clinical experience, operational expertise, and research knowledge to the MRN team.

Message Presenter

Who Should Attend?

  • C-suite
  • VP level
  • Medical Director
  • Clinical Development Director
  • Operational Director
  • Clinical Director
  • Clinical Innovation
  • Patient Engagement
  • Patient Advocacy
  • Patient Recruitment
  • Patient Services
  • Principal Investigator
  • Study Coordinators
  • Clinical Trial Manager
  • Clinical Research Coordinator
  • Director, Clinical Research

What You Will Learn

Attendees will learn:

  • Best practices for complex clinical visit delivery
  • Key considerations for specific patient populations
  • How to best support healthcare professionals in a complex DCT model

Xtalks Partner


MRN has led the way efficiently delivering high quality complex Decentralized Clinical Trials (DCT) from patients’ homes for over 16 years. We understand the complexities of today’s clinical trial environment and the burden placed on both patients and sites. Our decentralized trial and site support solutions are designed to ease these burdens, therefore accelerating patient recruitment, enrollment, and retention, maximizing the impact of the trial for the pharmaceutical sponsor – getting drugs to market faster. MRN are the catalysts of decentralized trials; combining the right clinical and digital DCT elements, to engineer the right solution for each trial. Learn more about MRN:

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account